CD274 and hepatocellular carcinoma: Combining QUE and anti-PD-1 antibodies can significantly inhibit the expression of PD-L1, IL-4, and IL-6 and raise the expression of CD8a, CD4, CD11b, and IFN-γ in HCC (148).